 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/11/2024 |
$1.77 |
$1.84 |
$1.74 |
$1.77 |
1.01M | | 04/12/2024 |
$1.83 |
$1.83 |
$1.60 |
$1.66 |
2.01M | | 04/15/2024 |
$1.63 |
$1.73 |
$1.63 |
$1.71 |
1.61M | | 04/16/2024 |
$1.67 |
$1.69 |
$1.53 |
$1.54 |
1.72M | | 04/17/2024 |
$1.54 |
$1.62 |
$1.35 |
$1.35 |
4.09M |
|
|
| Atossa Therapeutics is a clinical-stage biopharmaceutical company seeking to develop medicines in areas of oncology and infectious diseases, with a focus on breast cancer, other breast conditions and COVID-19. Co.'s drug under development for breast cancer and other breast conditions is Endoxifen which is being developed primarily in two settings: one to reduce tumor cell activity in breast cancer patients in the neoadjuvant setting, meaning prior to surgery; and another to reduce dense breast tissue in women. Co.'s two COVID-19 drugs under development are: AT-H201, an inhalation therapy for COVID-19 patients; and AT-301, a nasal spray for COVID-19 patients for at-home use. | |
|
Atossa Therapeutics (ATOS) has the following price history information. Looking back at ATOS historical stock prices for the last five trading days, on April 11, 2024, ATOS opened at $1.77, traded as high as $1.84 and as low as $1.74, and closed at $1.77. Trading volume was a total of 1.01M shares. On April 12, 2024, ATOS opened at $1.83, traded as high as $1.83 and as low as $1.60, and closed at $1.66. Trading volume was a total of 2.01M shares. On April 15, 2024, ATOS opened at $1.63, traded as high as $1.73 and as low as $1.63, and closed at $1.71. Trading volume was a total of 1.61M shares. On April 16, 2024, ATOS opened at $1.67, traded as high as $1.69 and as low as $1.53, and closed at $1.54. Trading volume was a total of 1.72M shares. On April 17, 2024, ATOS opened at $1.54, traded as high as $1.62 and as low as $1.35, and closed at $1.35. Trading volume was a total of 4.09M shares.
ATOS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atossa Therapeutics shares, starting with a $10,000 purchase of ATOS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/17/2024 |
|
| Start price/share: |
$244.80 |
|
| End price/share: |
$1.35 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.45% |
|
| Average Annual Total Return: |
-40.57% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$55.12 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 04/11/2024 | $1.77 | | 04/12/2024 | $1.66 | | 04/15/2024 | $1.71 | | 04/16/2024 | $1.54 | | 04/17/2024 | $1.35 |
|
|
Free ATOS Email Alerts:
